|Articles|July 15, 2002
Pharmacologic approach suitable for diabetic retinopathy
Baltimore-Diabetic retinopathy, although commonly encountered by retinal specialists, is challenging to treat because of the limitations of the two available modalities for early-stage disease.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
Inside the clinic: Surgeon shares real-world experience
3
What changed in glaucoma care in 2025: Surgeon perspective
4
FDA approvals in 2025: What changed and why it matters for ophthalmologists
5








































